Should I Buy BIO Stock in 2026?

Data-driven analysis and honest assessment for Bio-Rad Laboratories Inc

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $323.00

Decision Score

4.2/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)5/10

P/E data not available

Growth (20%)3/10

Declining -0%

Profitability (20%)2/10

Currently unprofitable

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)6/10

Decent FCF yield of 3.3%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$323.00

P/E Ratio

N/A

Revenue Growth

0.0%

Profit Margin

-0.3%

Market Cap

$8.7B

Dividend Yield

None

How BIO Compares to Competitors

Understanding how BIO stacks up against peers helps inform your investment decision.

How BIO Compares to Peers

Upcoming Events for BIO

+5 Reasons TO Buy BIO

1. High gross margins of 52%

moderate

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

-5 Reasons NOT to Buy BIO

1. Company is not profitable

high risk

Currently losing money. May need to raise capital or cut operations.

2. Minimal revenue growth

low risk

Growth of 0.0% barely keeps pace with inflation.

Who Should Buy BIO?

Investment Profile

Risk Level

Very High

Recommended Holding Period

5+ years (turnaround required)

Best For:

    Not Suitable For:

    • Growth Investors

      Limited 0% growth may disappoint

    • Income-Focused Retirees

      No dividend paid

    • Risk-Averse Investors

      Very High risk may cause uncomfortable volatility

    • Large Position Traders

      Lower liquidity may impact execution

    Consider These Alternatives

    If you're interested in BIO, compare these Healthcare peers:

    Pro tip: Compare BIO directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for BIO

    Frequently Asked Questions

    What is BIO stock price today?

    BIO (Bio-Rad Laboratories Inc) stock is trading at $323.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is BIO stock going up or down today?

    BIO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy BIO stock now?

    The decision to buy BIO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is BIO a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for BIO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is BIO stock overvalued or undervalued?

    Use our DCF valuation calculator to determine if BIO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

    What is BIO's P/E ratio?

    P/E ratio data for BIO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

    What is BIO's market cap?

    BIO (Bio-Rad Laboratories Inc) has a market capitalization of $8.73 billion, making it a small-cap stock.

    What is BIO's price to book ratio?

    BIO trades at a price-to-book (P/B) ratio of 1.30, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Bio-Rad Laboratories Inc

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.